Publicaciones en las que colabora con JOSÉ ANTONIO RAMOS ATANCE (17)

2013

  1. New serotonin 5-HT1A receptor agonists endowed with antinociceptive activity in vivo

    Journal of Medicinal Chemistry, Vol. 56, Núm. 20, pp. 7851-7861

2011

  1. New serotonin 5-HT 1A receptor agonists with neuroprotective effect against ischemic cell damage

    Journal of Medicinal Chemistry, Vol. 54, Núm. 23, pp. 7986-7999

2007

  1. Neurochemical effects of the endocannabinoid uptake inhibitor UCM707 in various rat brain regions

    Life Sciences, Vol. 80, Núm. 10, pp. 979-988

2006

  1. Chronic Δ9-tetrahydrocannabinol administration affects serotonin levels in the rat frontal cortex

    Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 372, Núm. 4, pp. 313-317

  2. UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disorders

    European Neuropsychopharmacology, Vol. 16, Núm. 1, pp. 7-18

2004

  1. Characterization of an anandamide degradation system in prostate epithelial PC-3 cells: Synthesis of new transporter inhibitors as tools for this study

    British Journal of Pharmacology, Vol. 141, Núm. 3, pp. 457-467

  2. Synthesis and structure-activity relationships of a new model of arylpiperazines. Part 7: Study of the influence of lipophilic factors at the terminal amide fragment on 5-HT1A affinity/selectivity

    Bioorganic and Medicinal Chemistry, Vol. 12, Núm. 6, pp. 1551-1557

2003

  1. Optimization of the Pharmacophore Model for 5-HT 7 R Antagonism. Design and Synthesis of New Naphtholactam and Naphthosultam Derivatives

    Journal of Medicinal Chemistry, Vol. 46, Núm. 26, pp. 5638-5650

  2. Design, synthesis and biological evaluation of new endocannabinoid transporter inhibitors

    European Journal of Medicinal Chemistry

  3. Design, synthesis, and biological evaluation of new inhibitors of the endocannabinoid uptake: Comparison with effects on fatty acid amidohydrolase

    Journal of Medicinal Chemistry, Vol. 46, Núm. 8, pp. 1512-1522

  4. Inhibition of fatty acid amidohydrolase, the enzyme responsible for the metabolism of the endocannabinoid anandamide, by analogues of arachidonoyl-serotonin

    Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 18, Núm. 3, pp. 225-231

2002

  1. Endocannabinoid transporter inhibitors

    Current Medicinal Chemistry - Central Nervous System Agents, Vol. 2, Núm. 2, pp. 129-141

  2. UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates hypokinetic and antinociceptive effects of anandamide

    European Journal of Pharmacology, Vol. 449, Núm. 1-2, pp. 99-103

2001

  1. Design, synthesis and biological evaluation of novel arachidonic acid derivatives as highly potent and selective endocannabinoid transporter inhibitors

    Journal of Medicinal Chemistry, Vol. 44, Núm. 26, pp. 4505-4508

  2. Nuevas tendencias en la utilidad terapeútica de los cannabinoides

    Anales de Química de la RSEQ, Núm. 2, pp. 14-21

2000

  1. First pharmacophoric hypothesis for 5-HT 7 antagonism

    Bioorganic and Medicinal Chemistry Letters, Vol. 10, Núm. 10, pp. 1097-1100

  2. Pd(0) amination of benzimidazoles as an efficient method towards new (benzimidazolyl)piperazines with high affinity for the 5-HT(1A) receptor

    Tetrahedron, Vol. 56, Núm. 20, pp. 3245-3253